Our Purpose drives us to create innovative solutions that make a meaningful impact on advancing the world of health™. At BD, we believe that people are at the heart of every breakthrough, solution, and step forward.
R. Bard, a medical device company founded in 1907 in Covington, Georgia. BD and its affiliates and subsidiaries (BD) do not accept any liability for fees for resumes from recruiters or employment agencies (“Agency”), without a binding, written recruitment agreement between BD and Agency describing the services and specific job openings (“Agreement”). They found repeat and serious violations of health and safety law that had resulted in two employees having partial finger amputations. The name “embecta” represents the company’s commitment to people living with diabetes and its corporate heritage, with the “em-” prefix evoking empathy for people living with diabetes and the empowerment of the new company and the “bect” imbibed from Becton.
At BD, your ideas, curiosity and purpose can makea global impact In December 2025, BD was sued by Tela Bio Inc., makers of a ovine forestomach matrix hernia mesh, who alleged that BD engaged in anticompetitive practices to push Tela out of the market for surgical meshes while raising prices for providers and patients. Food and Drug Administration and worldwide health agencies to coordinate recall activities. The approximately 2.8 million BD Q-Syte and 2.9 million BD Nexiva units containing 5 million BD Q-Syte devices that were recalled were distributed in the United States, Asia, Canada, Europe, Mexico, the Middle khelovipbangladesh.com/ East, South Africa, and South America.
By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase clinical efficiency, improve safety and expand access to healthcare. The company supports those on the frontlines of healthcare by developing transformative technologies, services and solutions that optimize clinical operations and improve care for patients. Operating across the globe, with more than 60,000 employees, BD delivers billions of products annually that have a positive impact on global healthcare. Based in Mexico City, to produce syringes, needles and clinical thermometers for the Mexican market. 1995 BD formed a subsidiary in India to manufacture insulin syringes and to market other medical and diagnostic products to the region. We welcome people with imagination and drive – people who want to grow, make a difference and help reinvent the future of healthcare.
1948 BD founders turn over the company to their sons. 1956 BD enters the Brazilian syringe market and quickly becomes the largest provider in the country with two modern plants and HQ in Sao Paulo. 1955 BD begins using AMI of France to manufacture steel tubes for hypodermic needles. 1981 A new plant is built in Plymouth, England to manufacture BD Vacutainer® system products and serve a growing European market.
1898 BD acquired its first patent for an all-glass syringe. “Doc” Fleischer, developer of the mercurial sphygmomanometer, merged his company with BD. 1940 BD launched the first sterilization technology for devices. 1947 BD hired Joseph Kleiner, who brings his multi-fit syringe and his idea for the evacuated tube.
2021 BD launched the first ready-to-use aqueous povidone-iodine (PVP-I) surgical irrigation solution. Bard might be a scam, please verify by searching for the posting on the careers page or contact us at Please be aware of potentially fraudulent job postings on other websites or suspicious recruiting email or text messages that attempt to collect your confidential information. Email AddressWe’ll send job alerts and updates here Create a job alert to be notified when positions that match your skills and location become available. Sign up to get the latest company news, events, and future opportunities straight to your inbox.
1954 Production of the first disposable syringes to be used in the Salk Polio vaccine trial takes place. 1988 BD launched the first safety engineered syringe. 1991 BD opens a central distribution center in Temsee, Belgium to ship medical products across Europe, the middle east, and Africa. 1995 A joint venture was established in China to produce medical products for China. 1995 A joint venture was established in China to produce medical products for China.\r\n
2015 BD became the first to integrate IV pumps with electronic health records. 2017 The first clinical lab application of artificial intelligence and robotics to automatically report and release negative urine cultures is utilized. 2019 BD launched the first venous stent to treat iliofemoral venous occlusive disease. 2014 BD launched the first FDA-approved drug coated balloon for peripheral artery disease.
In certain places, BD Medical also offers consulting and analytics related services. In 2024, BD announced it would acquire Edwards Lifesciences’ critical care unit for $4.2 billion. In July 2021, BD announced it would acquire surgical scaffold maker Tepha, after having acquired Velano Vascular earlier the same month. This agreement protects patents and intellectual properties of both companies ensuring the quality and integrity of Embecta Corporation’s cannulas used in their products. The transaction was completed later that year, and the company became a wholly-owned subsidiary of BD, rebranded as Bard.
